GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » Cyclically Adjusted Price-to-FCF

Glaukos (STU:6GJ) Cyclically Adjusted Price-to-FCF : (As of Jun. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Glaukos Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Glaukos Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Glaukos's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Cyclically Adjusted Price-to-FCF Chart

Glaukos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Glaukos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Glaukos's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Glaukos's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Glaukos's Cyclically Adjusted Price-to-FCF falls into.



Glaukos Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Glaukos's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Glaukos's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.646/131.7762*131.7762
=-0.646

Current CPI (Mar. 2024) = 131.7762.

Glaukos Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.038 100.560 -0.050
201409 -0.002 100.428 -0.003
201412 -0.058 99.070 -0.077
201503 -0.039 99.621 -0.052
201506 -0.041 100.684 -0.054
201509 -0.021 100.392 -0.028
201512 -0.027 99.792 -0.036
201603 -0.033 100.470 -0.043
201606 0.128 101.688 0.166
201609 0.022 101.861 0.028
201612 0.032 101.863 0.041
201703 0.039 102.862 0.050
201706 0.078 103.349 0.099
201709 0.103 104.136 0.130
201712 0.259 104.011 0.328
201803 -0.180 105.290 -0.225
201806 0.075 106.317 0.093
201809 0.088 106.507 0.109
201812 0.233 105.998 0.290
201903 -0.011 107.251 -0.014
201906 0.115 108.070 0.140
201909 -0.098 108.329 -0.119
201912 -0.088 108.420 -0.107
202003 -0.287 108.902 -0.347
202006 -0.273 108.767 -0.331
202009 -0.206 109.815 -0.247
202012 0.154 109.897 0.185
202103 -0.239 111.754 -0.282
202106 -0.071 114.631 -0.082
202109 0.136 115.734 0.155
202112 -0.264 117.630 -0.296
202203 0.058 121.301 0.063
202206 -0.432 125.017 -0.455
202209 -0.691 125.227 -0.727
202212 -0.244 125.222 -0.257
202303 -0.735 127.348 -0.761
202306 -0.266 128.729 -0.272
202309 -0.222 129.860 -0.225
202312 -0.279 129.419 -0.284
202403 -0.646 131.776 -0.646

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Glaukos  (STU:6GJ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Glaukos Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Glaukos's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Glaukos (STU:6GJ) Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (STU:6GJ) Headlines

No Headlines